Histogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Price :
Published : Nov-2017
No. of Pages : 19


Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in various applications which include hair regrowth and skincare; therapeutics including orthopedics and oncology. The company’s products are stabilized and bioactive in a biocompatible liquid formula. Its products are used as research tools for stem cell growth and therapeutics. It offers products to biotechnology companies and medical research institutes. Histogen is headquartered in San Diego, California, the US.

Histogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.


– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Mylan NV (MYL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, cardiovascular, central nervous systems, infectious disease, oncology, anesthesia and others. Mylan sells its products to retail pharmacy chains, wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The company has research and development facilities in the US, Canada, the UK, Ireland, Italy, Germany, India and Japan. Mylan is headquartered in Hatfield, Hertfordshire, the UK......

Koninklijke Philips N.V. (PHIA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical systems, consumer electronics and lighting products. It offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions. The company provides health & wellness, personal care and domestic appliances. Philips offers consumer luminaires, lumileds, professional lighting solutions, light sources & electronics and automotive lighting. The company also focuses on offering green products such as dimming backlights, and image processing inte......

Albany Molecular Research Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio drug discovery and development, manufacturing of Active Pharmaceutical Ingredients (API); process scale up development of fine chemicals and aseptic filling services for preclinical, clinical and commercial projects; manufacture of drug product (DP) for new and generic drugs and project management services. The company serves pharmaceutical, agrochemical and other sectors including detergent and cosmetics industries. AMRI offers drug discovery and development services across various therapeutic categories including infectious diseases, neurodegenerative disorders, metabolic disorders, cardiovascular and oncology. It has presence in the US, Europe and Asia. AMRI is head......

PTC Therapeutics Inc (PTCT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mutation; an orally active small molecule to reduce the function, activity and amount of BMI1; and an investigational oral therapeutic used for the treatment of spinal muscular atrophy. PTC Therapeutics' ataluren is in phase 3 for the treatment of nonsense mutation duchenne muscular dystrophy.The company works in collaboration with various biotechnology and pharmaceutical companies for advancing its pipeline candidates. PTC Therapeutics is headquartered in South Plainfield, New Jersey, the US. P......

Chemical Company of Malaysia Berhad (CCM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Chemical Company of Malaysia Berhad (CCM) is an industrial and specialty chemicals company. Its core business activities include provision of pharmaceuticals and healthcare products; chemical products and applications; and polymer coatings and applications. The company's product range find applications in a wide range of industries. CCM develops, manufactures and manufactures generic drugs and branded pharmaceutical products; provides water treatment solutions; and the polymer coating solutions for the rubber gloves industry. It also provides over-the-counter (OTC) brands such as CHAMPS, Diamelon, Donna, Flavettes and Proviton. The company has regional offices in Singapore, Indonesia and the Philippines. CCM is headquartered in Kuala Lumpur, Malaysia. Chemical Company of Malaysia......

Amarin Corp Plc (AMRN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of triglyceride levels in adult patients with severe hypertriglyceridemia and high triglyceride levels or mixed dyslipidemia. The company is also evaluating Vascepa as an add-on therapy to reduce major cardiovascular events in an at-risk patient population on statin therapy. Amarin markets the product in the US through wholesalers and specialty pharmacy providers. The company has subsidiaries in Ireland, the US, Scotland and Israel. Amarin is headquartered at Dublin, Ireland. Amarin Corp Plc (AMRN) - ......

Verona Pharma Plc (VRP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilator/anti-inflammatory drug which is being developed for a wide range of indications including chronic obstructive pulmonary disease (COPD), cystic fibrosis and asthma. The company has collaborations with King's College London McGill University and The University of North Carolina for conducting research and experimental studies and to the fund exploratory studies. The company has operations in North America and the UK. Verona Pharma is headquartered in London, the UK. Verona Pharma Plc (VRP) - ......

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company's product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs), Codex screening panels and kits, and enzyme platforms. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. Codexis discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. The company serves specialist businesses, pharmaceutical, food manufac......

Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products' manufacturers, and the federal gov......

ArQule Inc (ARQL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including activated checkpoint therapy platform and c-met survival protein platform. Its lead product candidate, ARQ 197 (tivantinib), an inhibitor of the c-Met receptor tyrosine kinase, is undergoing clinical-stage development. The other product pipeline of the company includes ARQ 087 is a multi-kinase inhibitor, ARQ 092 is an Akt inhibitor, ARQ 751 is a next-generation inhibitor of Akt, ARQ 761 is an activator of the damage response pathway, , ARQ 531 is a B-cell malignancies and ARQ 087 is an inhibi......